Xaira Therapeutics
Integrated biotechnology company focusing on leveraging artificial intelligence to transform drug discovery and development.
Launch date
Employees
Market cap
-
Enterprise valuation
$4.0—6.0b (Dealroom.co estimates Apr 2024.)
San Francisco California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
* | N/A | Spinout | |
* | $1.0b | Late VC | |
| Total Funding | $1.0b | ||